1. |
Cyclosporin does not appear to prevent cardiac hypertrophy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 2-2
&NA;,
Preview
|
PDF (868KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
2. |
The latest on phytotherapy for benign prostatic hyperplasia |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 3-3
&NA;,
Preview
|
PDF (770KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 4-4
&NA;,
Preview
|
PDF (806KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
4. |
New studies show cost effectiveness of psoriasis treatments |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 5-6
Mark Greener,
Preview
|
PDF (1632KB)
|
|
摘要:
Psoriasis is common, incurable and often psychologically devastating. For example, between 2 and 4% of Caucasians suffer from psoriasis. Some patients learn to live with the disfiguring plaques. However, psoriasis dramatically undermines other patients' quality of life - especially among women and younger sufferers.1Moreover, psoriasis imposes a heavy economic burden. In the US, annual outpatient costs for psoriasis range from $US1100 to $US6600 per patient depending on the treatment, with the total outpatient cost reaching $US3.2 billion in 1993 alone.2
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
5. |
Altretamine for ovarian cancerpatient costs high |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 6-6
&NA;,
Preview
|
PDF (800KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
6. |
AC makes the heart beat stronger? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 7-7
&NA;,
Preview
|
PDF (725KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
7. |
Gene therapypotential in peanut allergy? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 8-8
&NA;,
Preview
|
PDF (809KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
8. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 9-9
&NA;,
Preview
|
PDF (814KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 10-10
&NA;,
Preview
|
PDF (785KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
10. |
Honing in on low molecular weight heparins |
|
Inpharma Weekly,
Volume &NA;,
Issue 1184,
1999,
Page 11-12
Tracey Earl,
Preview
|
PDF (1639KB)
|
|
摘要:
A landmark study has shown that prolonged use of the low molecular weight heparin (LMWH) dalteparin sodium significantly reduces the incidence of mortality and myocardial infarction (MI) for up to 45 days in patients with unstable coronary artery disease (CAD). Preliminary results from the Fast Revascularization During Instability in Coronary Artery Disease (FRISC) II study were presented at 48th Annual Scientific Session of the American College of Cardiology [New Orleans, US; March 1999].
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|